UK markets closed

argenx SE (ARGX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
276.10-0.81 (-0.29%)
At close: 1:00PM EST
272.00 -4.10 (-1.48%)
After hours: 01:13PM EST
Full screen
Trade prices are not sourced from all markets
Previous close276.91
Open284.34
Bid268.83 x 1000
Ask283.47 x 800
Day's range273.89 - 285.41
52-week range248.21 - 382.15
Volume186,471
Avg. volume177,614
Market cap14.228B
Beta (5Y monthly)0.76
PE ratio (TTM)N/A
EPS (TTM)-7.24
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est350.41
  • Globe Newswire

    argenx to Present at Upcoming Investor Conferences

    November 10, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in several upcoming conferences: Guggenheim Healthcare Talks | Idea Forum | 3rd Annual Neuro/Immunology Day. Fireside chat on Monday, November 15, 2021 at 9:40 a.m. ET.Evercore ISI 4th Annual HealthCONx Conference. Fireside chat on Tuesday

  • Globe Newswire

    argenx Reports Third Quarter 2021 Financial Results and Provides Business Update

    – U.S. and Japan commercial teams fully staffed ahead of potential launches of efgartigimod in generalized myasthenia gravis (gMG) – – Signed partnership agreement with Medison for distribution of efgartigimod in Israel – – Wim Parys, M.D. to retire as Chief Medical Officer in March 2022 – – Management to host conference call today at 2:30 pm CEST (8:30 am ET) – October 28, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives

  • Globe Newswire

    argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021

    October 21, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Thursday, October 28, 2021 at 2:30 pm CET (8:30 am ET) to discuss its third quarter 2021 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website